HealthQuill Pharma
The World Health Organization’s laboratory network has detected six variants of poliovirus type 2 (cVDPV2) in sewage samples in war-torn Gaza and warned of a global spread if it is not contained.
Drugs Health Pharma

Poliovirus type 2 detected in sewage samples in war-torn Gaza: WHO

The World Health Organization’s laboratory network has detected six variants of poliovirus type 2 (cVDPV2) in sewage samples in war-torn Gaza and warned.

Read More
A person dies every minute due to AIDS-related causes, and the world is off-track to achieve its goals with a quarter of 39.9 million HIV people not able to receive treatment owing to a shortage of funds and an anti-rights push, a report stated.
Drugs Health Pharma

Fund crunch, anti-rights push, slowing global target to end AIDS, UN says

A person dies every minute due to AIDS-related causes, and the world is off-track to achieve its goals with a quarter of 39.9.

Read More
Agilent Technologies Inc., will acquire Canada-based Biovectra, a contract development and manufacturing company, for $925 million, according to a company statement.
Drugs Health Pharma

US-based Agilent Technologies to acquire Canada’s Biovectra for $925m

HQ Team July 23, 2024: Agilent Technologies Inc., will acquire Canada-based Biovectra, a contract development and manufacturing company, for $925 million, according to.

Read More
Britain’s Competition and Markets Authority (CMA) expressed concerns over Theramex's planned acquisition of Femoston and Duphaston stating it may reduce competition and choice for hormone replacement therapy (HRT) treatments in the country.
Health Medical Pharma

Irregular mealtimes increase anxiety and depression in shift workers, finds study

HQ Team, July 22, 2024: A study of over 22,000 airline crew members found that irregular and delayed meal times can lead to.

Read More
A 14-year-old boy from India’s southern state of Kerala died due to the Nipah virus and the state has identified 63 people in the high-risk category in a bid to prevent its transmission, a state government official said.
Drugs Health Pharma

Boy, 14, dies in India’s southern state of Kerala due to Nipah virus

A 14-year-old boy from India’s southern state of Kerala died due to the Nipah virus and the state has identified 63 people in.

Read More
Biogen Inc., a US biotechnology company, has got marketing authorisation from the European medicines regulator for its drug to treat neurodegenerative disease, amyotrophic lateral sclerosis.
Drugs Health Pharma

UK approves oral pill to treat advanced prostate cancer

HQ Team July 19, 2024: A new pill that treats hormone sensitive advance prostate cancer has been approved by the National Institute for.

Read More
nasal spray
Drugs Health Medical Pharma

Nasal sprays reduce cold duration in at-risk patients by 25%: Study

HQ Team July 18, 2024: A United Kingdom study found that Over-the-counter (OTC) nasal sprays can reduce the symptoms and duration of respiratory.

Read More
Conduct disorder is a result of extensive changes in the structure of the brain and is most noticeable in the cerebral cortex, or the outer layer, a study funded by the US National Institute of Mental Health finds.
Drugs Health Pharma

Conduct disorder in youth stems from changes in brain structure: NIMH

Conduct disorder is a result of extensive changes in the structure of the brain and is most noticeable in the cerebral cortex, or.

Read More
Japanese researchers have developed a non-invasive alternative to detect human papillomavirus by testing urine samples, a discovery that may transform cervical cancer screening.
Drugs Health Pharma

Urine tests can detect cervical cancer viruses, make screening easy

Japanese researchers have developed a non-invasive alternative to detect human papillomavirus by testing urine samples, a discovery that may transform cervical cancer screening.

Read More
British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.
Drugs Health Pharma

AstraZeneca acquires France’s Amolyt Pharma for $1.05 billion

British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.

Read More